🎉 M&A multiples are live!
Check it out!

Baumer Valuation Multiples

Discover revenue and EBITDA valuation multiples for Baumer and similar public comparables like Myomo, InfuSystem, and SmartVest.

Baumer Overview

About Baumer

Baumer SA develops solutions in hospitals and health industry equipments. It has various segments like Orthopedic Implants, Biomaterials, Sterilization, Infections Control, Surgical Centers, Water Treatment and solid residuals Health Treatment Divisions. The company also provides surgical center solutions, including anesthesia systems, lighting products, surgical tables, and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as fixation system locks, occipitocervial fixation systems, angled cervical cages, and posterior lumbar cages.


Founded

1952

HQ

Brazil
Employees

n/a

Website

baumer.com.br

Sectors

Medical Devices

Financials

Last FY Revenue $36.5M

Last FY EBITDA $10.0M

EV

$23.5M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Baumer Financials

See Baumer valuation multiples based on analyst estimates

Baumer P&L

In the most recent fiscal year, Baumer reported revenue of $36.5M and EBITDA of $10.0M.

Baumer expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Baumer valuation multiples based on analyst estimates
NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $36.5M XXX XXX XXX
Gross Profit XXX $22.5M XXX XXX XXX
Gross Margin XXX 62% XXX XXX XXX
EBITDA XXX $10.0M XXX XXX XXX
EBITDA Margin XXX 27% XXX XXX XXX
EBIT XXX $6.9M XXX XXX XXX
EBIT Margin XXX 19% XXX XXX XXX
Net Profit XXX $5.5M XXX XXX XXX
Net Margin XXX 15% XXX XXX XXX
Net Debt XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Baumer Stock Performance

Baumer has current market cap of BRL 186M (or $35.0M), and EV of BRL 125M (or $23.5M).

Market Cap Evolution

Baumer Stock Data

As of September 23, 2025, Baumer's stock price is BRL 19 (or $4).

See Baumer trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$23.5M $35.0M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Baumer Valuation Multiples

Baumer's trades at 0.6x EV/Revenue multiple, and 2.4x EV/EBITDA.

See valuation multiples for Baumer and 15K+ public comps

Baumer Financial Valuation Multiples

As of September 23, 2025, Baumer has market cap of $35.0M and EV of $23.5M.

Equity research analysts estimate Baumer's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Baumer's P/E ratio is not available.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $35.0M XXX $35.0M XXX XXX XXX
EV (current) $23.5M XXX $23.5M XXX XXX XXX
EV/Revenue n/a XXX 0.6x XXX XXX XXX
EV/EBITDA n/a XXX 2.4x XXX XXX XXX
EV/EBIT n/a XXX 3.4x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX 6.4x XXX XXX XXX
EV/FCF n/a XXX 4.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Baumer Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Baumer Margins & Growth Rates

Baumer's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Baumer's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Baumer's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Baumer and other 15K+ public comps

Baumer Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX 27% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX n/a XXX XXX XXX
Opex per Employee XXX XXX n/a XXX XXX XXX
S&M Expenses to Revenue XXX XXX 25% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 3% XXX XXX XXX
Opex to Revenue XXX XXX 43% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Baumer Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Baumer M&A and Investment Activity

Baumer acquired  XXX companies to date.

Last acquisition by Baumer was  XXXXXXXX, XXXXX XXXXX XXXXXX . Baumer acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Baumer

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Baumer

When was Baumer founded? Baumer was founded in 1952.
Where is Baumer headquartered? Baumer is headquartered in Brazil.
Is Baumer publicy listed? Yes, Baumer is a public company listed on BVMF.
What is the stock symbol of Baumer? Baumer trades under BALM4 ticker.
When did Baumer go public? Baumer went public in 2005.
Who are competitors of Baumer? Similar companies to Baumer include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Baumer? Baumer's current market cap is $35.0M
Is Baumer profitable? Yes, Baumer is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.